Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy.
about
Strongyloides hyperinfection syndrome: an emerging global infectious diseaseRandomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasisMass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, EcuadorUsefulness of Strongyloides stercoralis serology in the management of patients with eosinophilia.Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community.Strongyloidiasis in transplant patients.A 55-year-old male immigrant with lymphoma and Gram-negative sepsisStrongyloides stercoralis: systematic review of barriers to controlling strongyloidiasis for Australian indigenous communitiesThe laboratory diagnosis and follow up of strongyloidiasis: a systematic review.Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma.Accuracy of five serologic tests for the follow up of Strongyloides stercoralis infection.Intestinal parasites of children and adults in a remote Aboriginal community of the Northern Territory, Australia, 1994-1996.Evaluation of an indirect immunofluorescence assay for strongyloidiasis as a tool for diagnosis and follow-upType 2 Diabetes Mellitus Is Associated with Strongyloides stercoralis Treatment Failure in Australian Aboriginals.Use of dried blood spots to define antibody response to the Strongyloides stercoralis recombinant antigen NIEDecreasing intestinal parasites in recent Northern California refugeesStrongyloidiasis--the most neglected of the neglected tropical diseases?Diagnostic accuracy of five serologic tests for Strongyloides stercoralis infection.Chronic Larva Currens Following Tourist Travel to the Gambia and Southeast Asia Over 20 Years Ago.Strongyloidiasis Current Status with Emphasis in Diagnosis and Drug ResearchEvidence-Based Guidelines for Screening and Management of Strongyloidiasis in Non-Endemic Countries.The National Strongyloides Working Group in Australia 10 workshops on: commendations and recommendations.A coproantigen diagnostic test for Strongyloides infection.Serologic Monitoring of Public Health Interventions against Strongyloides stercoralis.Strongyloides stercoralis seroprevalence in Vietnam.Dry selection and wet evaluation for the rational discovery of new anthelminticsPaediatric Strongyloidiasis in Central AustraliaArgument for Inclusion of Strongyloidiasis in the Australian National Notifiable Disease ListThe Unique Life Cycle of Strongyloides stercoralis and Implications for Public Health ActionApplication of PCR-Based Tools to Explore Strongyloides Infection in People in Parts of Northern AustraliaTrends in Strongyloides stercoralis Faecal Larvae Detections in the Northern Territory, Australia: 2002 to 2012
P2860
Q28271599-95C5CEF5-780B-4FB7-A49A-A3774C0E83CFQ28479270-9C0410D3-0266-4E07-B6A7-FDF1677F9E8CQ28550729-E5F5BB5B-CF30-44B2-A30B-3C242F4AA5D3Q33588485-5553C1E7-86F1-4838-B936-373848461D47Q33728677-52D83948-5C49-4174-9084-0522F7A4F628Q34036101-8FD2D2ED-EDF4-4F8B-A11F-6186ED1D2E49Q34238397-6A6001FC-495D-4504-8807-760DAE47DC10Q34256904-C2E5ABC5-2771-405B-B115-E2797D308C96Q34563642-0107CE8A-39ED-4FA2-A2C3-C0D428ACB897Q34829109-8E6C59D0-DB01-4108-92D0-8C49DD0C1ACAQ35068368-850DAC1B-BBF5-4E1A-A845-8A684FDB9869Q35539314-71AF717F-627C-46D1-A564-DE05FB04E009Q35636098-680A095F-D121-4400-97D6-869C8221451CQ35752033-F9579140-5E2A-4369-9CD1-F6C29A380917Q35934745-E0BC5563-3481-42F5-BA54-BD472991F3E8Q36523029-62D84D16-A04E-4FAA-8756-96D7014985DBQ37425812-CBB5EA90-48F9-4F3E-AA62-8DFBF61675A8Q37473403-C71172D6-DC50-4C77-BAA3-6C2DFA9F6936Q38888489-315D7059-3331-4E33-874C-A8AE819474F3Q39140120-E14AAF75-401C-4B5B-A59C-757A5C88A1FBQ39393623-BBCB9CAC-373C-412C-BDE1-202E8B8DE478Q39409966-AA536497-E917-488A-94F4-7C95E3057E86Q39502404-F2797C42-78CA-4235-B6B3-9921494D029DQ40118366-4A872F1F-0FE1-43DD-8EA0-0B0A3582B316Q47779035-D41C9AED-C5A5-4D36-9BE3-7A3FDD765197Q56984963-94912C8F-7869-4348-95B1-D3D016920A48Q57144001-988859AF-FCEA-4BA2-9ABB-702122D8C437Q57144462-0B1C1621-778B-45AB-B11B-2042CC87E93AQ57145085-14933664-63F9-48CB-91F0-1B3213411C5CQ57151136-DBE06477-D052-4DA4-B329-78E640FDCB84Q57153172-556467BD-F179-47BF-9182-C994442E5D71
P2860
Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Utility of serological follow- ...... er anthelminthic chemotherapy.
@en
Utility of serological follow- ...... er anthelminthic chemotherapy.
@nl
type
label
Utility of serological follow- ...... er anthelminthic chemotherapy.
@en
Utility of serological follow- ...... er anthelminthic chemotherapy.
@nl
prefLabel
Utility of serological follow- ...... er anthelminthic chemotherapy.
@en
Utility of serological follow- ...... er anthelminthic chemotherapy.
@nl
P1476
Utility of serological follow- ...... er anthelminthic chemotherapy.
@en
P2093
James S McCarthy
Karen Dempsey
P304
P356
10.1016/J.TRSTMH.2005.12.006
P50
P577
2006-03-23T00:00:00Z